摘要
二十世纪下半叶,合成化学品在各种工业和农业应用中的应用急剧增加,导致由于未受到环境污染而影响生态系统各个营养水平的特定扰动。尽管内分泌干扰化学品(EDCs)如杀虫剂和增塑剂越来越有用,但它们对环境健康的法定影响却令人担忧。 EDCs可以破坏生理稳态,导致发育和生殖异常。临床前动物实验以及流行病学研究都将EDC暴露与代谢综合征,2型糖尿病以及心血管健康等代谢紊乱联系起来。在这里,我们简要回顾一下EDCs对代谢紊乱的法定影响以及它们对环境健康的影响。最后,考虑到这种相互作用的复杂性,已经解决了与EDC诱导的代谢疾病分类作为全球疾病负担的风险因素有关的困难
关键词: 内分泌干扰化学物质,代谢途径,危险因素,全球疾病负担,血管疾病,代谢紊乱。
图形摘要
Current Drug Targets
Title:Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases
Volume: 19 Issue: 9
关键词: 内分泌干扰化学物质,代谢途径,危险因素,全球疾病负担,血管疾病,代谢紊乱。
摘要: The latter half of the twentieth century has witnessed a humongous spurt in the use of synthetic chemicals in a wide variety of industrial and agricultural applications leading to specific perturbations affecting every trophic level of the ecosystems due to unmitigated environmental contamination. Despite the incremental usefulness of endocrine disrupting chemicals (EDCs) such as pesticides and plasticizers, their statutory impact on environmental health is assuming worrisome proportions. The EDCs can disrupt physiological homeostasis resulting in developmental and reproductive abnormalities. Both preclinical animal experiments, as well as epidemiological studies, have correlated EDC exposure with metabolic disorders such as metabolic syndrome, type 2 diabetes as well as cardiovascular health. Here we briefly review the statutory impact of EDCs on metabolic disruption as well as their impact on environmental health. Finally, difficulties pertaining to the categorization of EDC induced metabolic diseases as risk factors for global disease burden have been addressed taking into account the complexity of such interactions.
Export Options
About this article
Cite this article as:
Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases, Current Drug Targets 2018; 19 (9) . https://dx.doi.org/10.2174/1389450119666180514122244
DOI https://dx.doi.org/10.2174/1389450119666180514122244 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research Antioxidant Agents in Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Potential Impact of Genetic Variants in Nrf2 Regulated Antioxidant Genes and Risk Prediction of Diabetes and Associated Cardiac Complications
Current Medicinal Chemistry Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Current Pharmaceutical Design Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered
Current Vascular Pharmacology What Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts
Current Alzheimer Research Structure and Function of the Von Willebrand Factor A1 Domain
Current Protein & Peptide Science Classification of Pharynx from MRI Using a Visual Analysis Tool to Study Obstructive Sleep Apnea
Current Medical Imaging Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design Endothelial Changes in Individuals with Prehypertension
Current Hypertension Reviews Transglutaminases as Targets for Pharmacological Inhibition
Mini-Reviews in Medicinal Chemistry Imaging and Laboratory Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design The Causal Relationship Between Passive Smoking and Inflammation on the Development of Cardiovascular Disease: A Review of the Evidence
Inflammation & Allergy - Drug Targets (Discontinued) Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Current Pharmaceutical Design The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment
Current Drug Metabolism Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry Prognostic Value of Coronary Artery Calcification
Vascular Disease Prevention (Discontinued) Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Ivabradine: Cardiovascular Effects
Recent Patents on Cardiovascular Drug Discovery